The predicted mechanisms and evidence of probiotics on type 2 diabetes mellitus (T2DM)

References

• Abbasi, B., Ghiasvand, R., and Mirlohi, M., 2017. Kidney Function Improvement by Soy Milk Containing Lactobacillus plantarum A7 in Type 2 Diabetic Patients With Nephropathy: a Double-Blinded Randomized Controlled Trial. Iranian journal of kidney diseases, 11 (1), 36–43.
   PubMed Web of Science ®Google Scholar
• Alipour, B., et al., 2014. Effects of Lactobacillus casei supplementation on disease activity and inflammatory cytokines in rheumatoid arthritis patients: a randomized double-blind clinical trial. International journal of rheumatic diseases, 17 (5), 519–527.
   PubMed Web of Science ®Google Scholar
• Anhê, F.F., et al., 2015. A polyphenol-rich cranberry extract protects from diet-induced obesity, insulin resistance and intestinal inflammation in association with increased Akkermansia spp. population in the gut microbiota of mice. Gut, 64 (6), 872–883.
   PubMed Web of Science ®Google Scholar
• Archer, A.C., Muthukumar, S.P., and Halami, P.M., 2021. Lactobacillus fermentum MCC2759 and MCC2760 Alleviate Inflammation and Intestinal Function in High-Fat Diet-Fed and Streptozotocin-Induced Diabetic Rats. Probiotics and antimicrobial proteins, 13(4), 1068–1080.
   PubMed Web of Science ®Google Scholar
• Aschner, P., 2020. Insulin Therapy in Type 2 Diabetes. American journal of therapeutics, 27 (1), e79–e90.
   PubMed Web of Science ®Google Scholar
• Bajinka, O., et al., 2020a. Gut microbiota and the human physiological changes. Annals of microbiology, 70 (1), 65.
   Web of Science ®Google Scholar
• Bajinka, O., et al., 2020b. Extrinsic factors influencing gut microbes, the immediate consequences and restoring eubiosis. AMB express, 10 (1), 130.
   PubMed Web of Science ®Google Scholar
• Balakumar, M., et al., 2018. Improvement in glucose tolerance and insulin sensitivity by probiotic strains of Indian gut origin in high-fat diet-fed C57BL/6J mice. European journal of nutrition, 57 (1), 279–295.
   PubMed Web of Science ®Google Scholar
• Brahe, L.K., et al., 2015. Dietary modulation of the gut microbiota–a randomised controlled trial in obese postmenopausal women. The british journal of nutrition, 114 (3), 406–417.
   PubMed Web of Science ®Google Scholar
• Cabello-Olmo, M., et al., 2019. A fermented food product containing lactic acid bacteria protects ZDF Rats from the development of type 2 diabetes. Nutrients, 11 (10), 2530.
   PubMed Web of Science ®Google Scholar
• Camacho, F., Macedo, A., and Malcata, F., 2019. Potential industrial applications and commercialization of microalgae in the functional food and feed industries: a short review. Marine drugs., 17 (6), 312.
   PubMed Web of Science ®Google Scholar
• Candela, M., et al., 2016. Modulation of gut microbiota dysbioses in type 2 diabetic patients by macrobiotic Ma-Pi 2 diet. The British journal of nutrition, 116 (1), 80–93.
   PubMed Web of Science ®Google Scholar
• Canfora, E.E., Jocken, J.W., and Blaak, E.E., 2015. Short-chain fatty acids in control of body weight and insulin sensitivity. Nature reviews endocrinology, 11 (10), 577–591.
   PubMed Web of Science ®Google Scholar
• Cani, P.D., and Delzenne, N.M., 2009. The role of the gut microbiota in energy metabolism and metabolic disease. Current pharmaceutical design, 15 (13), 1546–1558.
   PubMed Web of Science ®Google Scholar
• Cao, Q., et al., 2018. Effect of probiotic treatment on cirrhotic patients with minimal hepatic encephalopathy: A meta-analysis. Hepatobiliary & pancreatic diseases international. Hepatobiliary & pancreatic diseases international, 17 (1), 9–16.
   PubMedGoogle Scholar
• Cavalcante, R.G.S., et al., 2019. The probiotic Lactobacillus fermentum 296 attenuates cardiometabolic disorders in high fat diet-treated rats. Nutrition, metabolism, and cardiovascular diseases NMCD, 29 (12), 1408–1417.
   PubMed Web of Science ®Google Scholar
• Cavallari, J.F., et al., 2017. Muramyl dipeptide-based postbiotics mitigate obesity-induced insulin resistance via IRF4. Cell metabolism, 25 (5), 1063–1074.e3. e1063.
   PubMed Web of Science ®Google Scholar
• Chávez-Carbajal, A., et al., 2020. Characterization of the Gut Microbiota of Individuals at Different T2D Stages Reveals a Complex Relationship with the Host. Microorganisms, 8 (1), 94.
   PubMed Web of Science ®Google Scholar
• Chen, K., et al., 2020. Effect of resveratrol on intestinal tight junction proteins and the gut microbiome in high-fat diet-fed insulin resistant mice. International journal of food sciences and nutrition, 71 (8), 965–978.
   PubMed Web of Science ®Google Scholar
• Clark, A., and Mach, N., 2016. Exercise-induced stress behavior, gut-microbiota-brain axis and diet: a systematic review for athletes. Journal of the international society of sports nutrition., 13, 43.
   PubMed Web of Science ®Google Scholar
• Derosa, G., and Maffioli, P., 2012. α-Glucosidase inhibitors and their use in clinical practice. Archives of medical science: AMS, 8 (5), 899–906.
   PubMed Web of Science ®Google Scholar
• Derrien, M., Alvarez, A.S., and de Vos, W.M., 2019. The gut microbiota in the first decade of life. Trends in microbiology, 27 (12), 997–1010.
   PubMed Web of Science ®Google Scholar
• Dhameja, M., and Gupta, P., 2019. Synthetic heterocyclic candidates as promising α-glucosidase inhibitors: An overview. European journal of medicinal chemistry, 176, 343–377.
   PubMed Web of Science ®Google Scholar
• Dhiman, R.K., et al., 2020. Comparative efficacy of treatment options for minimal hepatic encephalopathy: a systematic review and network meta-analysis. Clinical gastroenterology and hepatology, 18 (4), 800–812.e25.
   PubMed Web of Science ®Google Scholar
• Dovi, K.S., Bajinka, O., and Conteh, I., 2022. Evidence and possible mechanisms of probiotics in the management of type 1 diabetes mellitus. Journal of diabetes and metabolic disorders, 21 (1), 1081–1094.
   PubMed Web of Science ®Google Scholar
• Feingold, K. R., et al., 2022. Oral and injectable (non-insulin) pharmacological agents for the treatment of type 2 diabetes. (K. R. Feingold, et al. eds). South Dartmouth, MA: MDText.com, Inc.
   Google Scholar
• Feizollahzadeh, S., et al., 2017. Effect of probiotic soy milk on serum levels of adiponectin, inflammatory mediators, lipid profile, and fasting blood glucose among patients with type II diabetes mellitus. Probiotics and Antimicrobial Proteins, 9 (1), 41–47.
   PubMed Web of Science ®Google Scholar
• Firouzi, S., et al., 2017. Effect of multi-strain probiotics (multi-strain microbial cell preparation) on glycemic control and other diabetes-related outcomes in people with type 2 diabetes: a randomized controlled trial. European journal of nutrition, 56 (4), 1535–1550.
   PubMed Web of Science ®Google Scholar
• Fujii, Y., Khasnobish, A., and Morita, H., 2019. Relationship between Alzheimer’s Disease and the Human Microbiome. Alzheimer’s Disease. T. Wisniewski. Brisbane, AU, Codon Publications.
   Google Scholar
• Gao, X., et al., 2019. Effect of heat-killed Streptococcus thermophilus on type 2 diabetes rats. Peer journal, 7, e7117.
   PubMed Web of Science ®Google Scholar
• Gholizadeh, P., et al., 2019. Microbial balance in the intestinal microbiota and its association with diabetes, obesity and allergic disease. Microbial pathogenesis, 127, 48–55.
   PubMed Web of Science ®Google Scholar
• Giulietti, A., et al., 2007. Monocytes from type 2 diabetic patients have a pro-inflammatory profile. 1,25-Dihydroxyvitamin D(3) works as anti-inflammatory. Diabetes research and clinical practice, 77 (1), 47–57.
   PubMed Web of Science ®Google Scholar
• Goyal, R., and Jialal, I., 2021. Diabetes mellitus type 2. Treasure Island, FL: StatPearls Publishing.
   Google Scholar
• Guilbaud, A., et al., 2020. The effect of lactobacillus fermentum ME-3 treatment on glycation and diabetes complications. Molecular nutrition & food research, 64 (6), e1901018.
   PubMed Web of Science ®Google Scholar
• Guo, V.Y., et al., 2018. Fetuin-A levels and risk of type 2 diabetes mellitus: a systematic review and meta-analysis. Acta diabetologica, 55 (1), 87–98.
   PubMed Web of Science ®Google Scholar
• Gurung, M., et al., 2020. Role of gut microbiota in type 2 diabetes pathophysiology. EBio medicine, 51, 102590.
   PubMed Web of Science ®Google Scholar
• Hallajzadeh, J., Eslami, R.D., and Tanomand, A., 2020. Effect of Lactobacillus delbrueckii Subsp. lactis PTCC1057 on Serum Glucose, Fetuin-A, and Sestrin 3 Levels in Streptozotocin-Induced Diabetic Mice. Probiotics and Antimicrobial Proteins, 13(2), 383–389.
   Google Scholar
• Han, J.L., and Lin, H.L., 2014. Intestinal microbiota and type 2 diabetes: from mechanism insights to therapeutic perspective. World journal of gastroenterology, 20 (47), 17737–17745.
   PubMed Web of Science ®Google Scholar
• Harsch, I.A., and Konturek, P.C., 2018. The role of gut microbiota in obesity and type 2 and type 1 diabetes mellitus: new insights into “old” diseases. Medical Science, 6 (2), 32.
   Google Scholar
• Hermann, L.S., 1990. Biguanides and sulfonylureas as combination therapy in NIDDM. Diabetes care, 13 (Supplement_3), 37–41.
   PubMedGoogle Scholar
• Hill, C., et al., 2014. Expert consensus document. The International Scientific Association for Probiotics and Prebiotics consensus statement on the scope and appropriate use of the term probiotic. Nature reviews. gastroenterology & hepatology, 11 (8), 506–514.
   PubMed Web of Science ®Google Scholar
• Hirayama, T., et al., 2011. Toll-like receptors and their adaptors are regulated in macrophages after phagocytosis of lipopolysaccharide-coated titanium particles. Journal of orthopaedic research, 29 (7), 984–992.
   PubMed Web of Science ®Google Scholar
• Holzapfel, W.H., et al., 2001. Taxonomy and important features of probiotic microorganisms in food and nutrition. The American journal of clinical nutrition, 73 (2 Suppl), 365s–373s.
   PubMed Web of Science ®Google Scholar
• Hsieh, M.C., et al., 2018. The beneficial effects of Lactobacillus reuteri ADR-1 or ADR-3 consumption on type 2 diabetes mellitus: a randomized, double-blinded, placebo-controlled trial. Scientific reports, 8 (1), 16791.
   PubMedGoogle Scholar
• Hsieh, P.S., et al., 2020. Lactobacillus salivarius AP-32 and Lactobacillus reuteri GL-104 decrease glycemic levels and attenuate diabetes-mediated liver and kidney injury in db/db mice. BMJ open diabetes research care, 8 (1), e001028.
   PubMed Web of Science ®Google Scholar
• Hsu, Y.J., et al., 2015. Effect of intestinal microbiota on exercise performance in mice. Journal of strength and conditioning research, 29 (2), 552–558.
   PubMed Web of Science ®Google Scholar
• Hu, Z., Liu, X., and Yang, M., 2021. Evidence and potential mechanisms of Jin-Gui Shen-Qi Wan as a treatment for type 2 diabetes mellitus: a systematic review and meta-analysis. Frontiers in pharmacology, 12, 699932.
   PubMed Web of Science ®Google Scholar
• Jeyaraman, M.M., et al., 2020. Resveratrol for adults with type 2 diabetes mellitus. The cochrane database of systematic reviews, 1 (1), CD011919.
   PubMedGoogle Scholar
• Jia, L., et al., 2017. Anti-diabetic effects of clostridium butyricum CGMCC0313.1 through promoting the growth of gut butyrate-producing bacteria in type 2 diabetic mice. Scientific reports, 7 (1), 7046.
   PubMedGoogle Scholar
• Karlsson, F.H., et al., 2013. Gut metagenome in European women with normal, impaired and diabetic glucose control. Nature, 498 (7452), 99–103.
   PubMed Web of Science ®Google Scholar
• Kerimi, A., et al., 2017. Pomegranate juice, but not an extract, confers a lower glycemic response on a high-glycemic index food: randomized, crossover, controlled trials in healthy subjects. The American journal of clinical nutrition, 106 (6), 1384–1393.
   PubMed Web of Science ®Google Scholar
• Kesika, P., Sivamaruthi, B.S., and Chaiyasut, C., 2019. Do probiotics improve the health status of individuals with diabetes mellitus? a review on outcomes of clinical trials. BioMed research international, 2019, 1531567.
   PubMed Web of Science ®Google Scholar
• Khalili, L., et al., 2019. The effects of lactobacillus casei on glycemic response, serum sirtuin1 and fetuin-a levels in patients with type 2 diabetes mellitus: a randomized controlled trial. Iranian biomedical journal, 23 (1), 68–77.
   PubMedGoogle Scholar
• Khosravi, A., et al., 2020. Study on the interaction of triaryl-dihydro-1,2,4-oxadiazoles with α-glucosidase. Daru : journal of faculty of pharmacy, tehran university of medical sciences, 28 (1), 109–117.
   PubMed Web of Science ®Google Scholar
• Kobyliak, N., et al., 2018. Effect of alive probiotic on insulin resistance in type 2 diabetes patients: Randomized clinical trial. Diabetes & metabolic syndrome, 12 (5), 617–624.
   PubMed Web of Science ®Google Scholar
• Kocsis, T., et al., 2020. Probiotics have beneficial metabolic effects in patients with type 2 diabetes mellitus: a meta-analysis of randomized clinical trials. Scientific reports, 10 (1), 11787.
   PubMed Web of Science ®Google Scholar
• Kordjazy, N., et al., 2018. Role of toll-like receptors in inflammatory bowel disease. Pharmacological research, 129, 204–215.
   PubMed Web of Science ®Google Scholar
• Lachmann, R.H., 2004. alpha-glucosidase (CHO) (Genzyme). Current opinion in investigational drugs, 5 (10), 1101–1110.
   PubMedGoogle Scholar
• Lam, D. W., LeRoith, D., et al., 2000. Metabolic syndrome. (K. R. Feingold, B. Anawalt, A. Boyce, eds.). South Dartmouth, MA: MDText.com, Inc.
   Google Scholar
• Larsen, N., et al., 2010. Gut microbiota in human adults with type 2 diabetes differs from non-diabetic adults. PLoS one, 5 (2), e9085.
   PubMed Web of Science ®Google Scholar
• Lau, E., et al., 2015. Beyond gut microbiota: understanding obesity and type 2 diabetes. Hormones, 14 (3), 358–369.
   PubMedGoogle Scholar
• Layer, P., et al., 1995. Ileal release of glucagon-like peptide-1 (GLP-1). Association with inhibition of gastric acid secretion in humans. Digestive diseases and sciences, 40 (5), 1074–1082.
   PubMed Web of Science ®Google Scholar
• Le Wang, Q.S., et al., 2020. Evaluation of the hypoglycemic effect of probiotics via directly consuming glucose in intestines of STZ-induced diabetic mice and glucose waterinduced diabetic mice. Journal of functional foods, 64 (103614), 103614–104646.
   Google Scholar
• Lee, E., et al., 2018. Lactobacillus plantarum Strain Ln4 Attenuates Diet-Induced Obesity, insulin resistance, and changes in hepatic mRNA levels associated with glucose and lipid metabolism. Nutrients, 10 (5), 643.
   PubMed Web of Science ®Google Scholar
• Li, B.Y., et al., 2019. Targeting gut microbiota for the prevention and management of diabetes mellitus by dietary natural products. Foods, 8 (10), 440.
   PubMed Web of Science ®Google Scholar
• Li, X., et al., 2017. Effects of Lactobacillus casei CCFM419 on insulin resistance and gut microbiota in type 2 diabetic mice. Beneficial microbes, 8 (3), 421–432.
   PubMed Web of Science ®Google Scholar
• Li, X., et al., 2016. A comparative study of the antidiabetic effects exerted by live and dead multi-strain probiotics in the type 2 diabetes model of mice. Food & function, 7 (12), 4851–4860.
   PubMed Web of Science ®Google Scholar
• Liang, T., et al., 2021. Probiotics supplementation improves hyperglycemia, hypercholesterolemia, and hypertension in type 2 diabetes mellitus: An update of meta-analysis. Critical reviews in food science and nutrition, 61 (10), 1670–1688.
   PubMed Web of Science ®Google Scholar
• Madempudi, R.S., et al., 2019. Efficacy of UB0316, a multi-strain probiotic formulation in patients with type 2 diabetes mellitus: A double blind, randomized, placebo controlled study. PLoS One, 14 (11), e0225168.
   PubMed Web of Science ®Google Scholar
• Mafi, A., et al., 2018. Metabolic and genetic response to probiotics supplementation in patients with diabetic nephropathy: a randomized, double-blind, placebo-controlled trial. Food & function, 9 (9), 4763–4770.
   PubMed Web of Science ®Google Scholar
• Makki, K., et al., 2018. The impact of dietary fiber on gut microbiota in host health and disease. Cell host & microbe, 23 (6), 705–715.
   PubMed Web of Science ®Google Scholar
• Markowiak-Kopeć, P., and Śliżewska, K., 2020. The effect of probiotics on the production of short-chain fatty acids by human intestinal microbiome. Nutrients, 12 (4), 1107.
   PubMed Web of Science ®Google Scholar
• Meng, J., et al., 2021. The role of traditional Chinese medicine in the treatment of cognitive dysfunction in type 2 diabetes. Journal of Ethnopharmacology, 280, 114464.
   PubMed Web of Science ®Google Scholar
• Milne, J.C., et al., 2007. Small molecule activators of SIRT1 as therapeutics for the treatment of type 2 diabetes. Nature, 450 (7170), 712–716.
   PubMed Web of Science ®Google Scholar
• Miraghajani, M., et al., 2019. Probiotic soy milk consumption and renal function among type 2 diabetic patients with nephropathy: a randomized controlled clinical trial. Probiotics and antimicrobial proteins, 11 (1), 124–132.
   PubMed Web of Science ®Google Scholar
• Miraghajani, M., et al., 2017. The impact of probiotic soy milk consumption on oxidative stress among type 2 diabetic kidney disease patients: a randomized controlled clinical trial. Journal of renal nutrition, 27 (5), 317–324.
   PubMed Web of Science ®Google Scholar
• Mirmiranpour, H., et al., 2020. Effects of probiotic, cinnamon, and synbiotic supplementation on glycemic control and antioxidant status in people with type 2 diabetes; a randomized, double-blind, placebo-controlled study. Journal of diabetes and metabolic disorders, 19 (1), 53–60.
   PubMed Web of Science ®Google Scholar
• Mishra, S.P., et al., 2019. Probiotics and prebiotics for the amelioration of type 1 diabetes: present and future perspectives. Microorganisms, 7 (3), 67.
   PubMed Web of Science ®Google Scholar
• Mobini, R., et al., 2017. Metabolic effects of Lactobacillus reuteri DSM 17938 in people with type 2 diabetes: A randomized controlled trial. Diabetes, obesity & metabolism, 19 (4), 579–589.
   PubMed Web of Science ®Google Scholar
• Müller, T.D., et al., 2019. Glucagon-like peptide 1 (GLP-1). Molecular metabolism, 30, 72–130.
   PubMed Web of Science ®Google Scholar
• Muñoz-Garach, A., Diaz-Perdigones, C., and Tinahones, F.J., 2016. Gut microbiota and type 2 diabetes mellitus. Endocrinologia y Nutricion : organo de la Sociedad Espanola de Endocrinologia y Nutricion, 63 (10), 560–568.
   PubMedGoogle Scholar
• Napolitano, A., et al., 2014. Novel gut-based pharmacology of metformin in patients with type 2 diabetes mellitus. PLoS One, 9 (7), e100778.
   PubMed Web of Science ®Google Scholar
• Nicholson, M.K., Ghazal Asswad, R., and Wilding, J.P., 2021. Dapagliflozin for the treatment of type 2 diabetes mellitus - an update. Expert Opinion on Pharmacotherapy, 22 (17), 2303–2310.
   PubMed Web of Science ®Google Scholar
• NIH. (2021). Glucagon-like peptide 1. https://pubchem.ncbi.nlm.nih.gov/compound/Glucagon-like-peptide-1
   Google Scholar
• Niibo, M., et al., 2019. Probiotic Lactobacillus gasseri SBT2055 improves insulin secretion in a diabetic rat model. Journal of dairy science, 102 (2), 997–1006.
   PubMed Web of Science ®Google Scholar
• Ogurtsova, K., et al., 2017. IDF Diabetes Atlas: Global estimates for the prevalence of diabetes for 2015 and 2040. Diabetes research and clinical practice, 128, 40–50.
   PubMed Web of Science ®Google Scholar
• Ojo, O., et al., 2020. The role of dietary fibre in modulating gut microbiota dysbiosis in patients with type 2 diabetes: a systematic review and meta-analysis of randomised controlled trials. Nutrients, 12 (11), 3239.
   PubMed Web of Science ®Google Scholar
• Olivares, M., et al., 2006. Oral administration of two probiotic strains, Lactobacillus gasseri CECT5714 and Lactobacillus coryniformis CECT5711, enhances the intestinal function of healthy adults. International journal of food microbiology, 107 (2), 104–111.
   PubMed Web of Science ®Google Scholar
• Park, K.Y., Kim, B., and Hyun, C.K., 2015. Lactobacillus rhamnosus GG improves glucose tolerance through alleviating ER stress and suppressing macrophage activation in db/db mice. Journal of clinical biochemistry and nutrition, 56 (3), 240–246.
   Google Scholar
• Peng, J., et al., 2014. Long term effect of gut microbiota transfer on diabetes development. Journal of autoimmunity, 53, 85–94.
   PubMed Web of Science ®Google Scholar
• Plaza-Diaz, J., et al., 2019. Mechanisms of action of probiotics. Advances in nutrition, 10 (suppl_1), S49–s66.
   PubMed Web of Science ®Google Scholar
• Plotkin, B.J., et al., 1996. Immune responsiveness in a rat model for type II diabetes (Zucker rat, fa/fa): susceptibility to Candida albicans infection and leucocyte function. Journal of medical microbiology, 44 (4), 277–283.
   PubMed Web of Science ®Google Scholar
• Prabhu, D., et al., 2018. Improvement in glucose tolerance and insulin sensitivity by probiotic strains of Indian gut origin in high-fat diet-fed C57BL/6J mice. European Journal of Nutrition, 57 (1), 279–295.
   PubMed Web of Science ®Google Scholar
• Pucci, A., Batterham, R. L., et al., 2000. Endocrinology of the Gut and the Regulation of Body Weight and Metabolism. (K. R. Feingold, B. Anawalt, A. Boyce, eds). South Dartmouth, MA: MDText.com, Inc.
   Google Scholar
• Qin, J., et al., 2012. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature, 490 (7418), 55–60.
   PubMed Web of Science ®Google Scholar
• Rachdaoui, N., 2020. Insulin: the friend and the foe in the development of type 2 diabetes mellitus. International journal of molecular sciences., 21 (5), 1770.
   PubMed Web of Science ®Google Scholar
• Raygan, F., et al., 2018. The effects of vitamin D and probiotic co-supplementation on mental health parameters and metabolic status in type 2 diabetic patients with coronary heart disease: A randomized, double-blind, placebo-controlled trial. Progress in Neuro-psychopharmacology & biological psychiatry, 84 (Pt A), 50–55.
   PubMedGoogle Scholar
• Razmpoosh, E., et al., 2019. The effect of probiotic supplementation on glycemic control and lipid profile in patients with type 2 diabetes: A randomized placebo controlled trial. Diabetes & metabolic syndrome, 13 (1), 175–182.
   PubMed Web of Science ®Google Scholar
• Ri, W., et al., 2015. Construction of yeast strains expressing long-acting glucagon-like peptide-1 (GLP-1) and their therapeutic effects on type 2 diabetes mellitus mouse model. Yi Chuan = Hereditas, 37 (2), 183–191.
   PubMedGoogle Scholar
• Rittiphairoj, T., et al., 2021. Probiotics Contribute to Glycemic Control in Patients with Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis. Advances in nutrition, 12 (3), 722–734.
   PubMed Web of Science ®Google Scholar
• Ross, M.C., et al., 2015. 16S gut community of the cameron county hispanic cohort. Microbiome, 3, 7.
   PubMed Web of Science ®Google Scholar
• Sabatini, S., et al., 2017. Oral probiotics in the management of gingivitis in diabetic patients: a double blinded randomized controlled study. Journal of biological regulators and homeostatic agents, 31 (2 Suppl 1), 197–202.
   PubMed Web of Science ®Google Scholar
• Sabico, S., et al., 2019. Effects of a 6-month multi-strain probiotics supplementation in endotoxemic, inflammatory and cardiometabolic status of T2DM patients: A randomized, double-blind, placebo-controlled trial. Clinical nutrition, 38 (4), 1561–1569.
   PubMed Web of Science ®Google Scholar
• Sabico, S., et al., 2017. Effects of a multi-strain probiotic supplement for 12 weeks in circulating endotoxin levels and cardiometabolic profiles of medication naïve T2DM patients: a randomized clinical trial. Journal of translational medicine, 15 (1), 249.
   PubMedGoogle Scholar
• Salgaço, M.K., et al., 2019. Relationship between gut microbiota, probiotics, and type 2 diabetes mellitus. Applied microbiology and biotechnology, 103 (23-24), 9229–9238.
   PubMed Web of Science ®Google Scholar
• Sato, J., et al., 2017. Probiotic reduces bacterial translocation in type 2 diabetes mellitus: A randomised controlled study. Scientific reports, 7 (1), 12115.
   PubMedGoogle Scholar
• Sciacqua, A., et al., 2021. Pharmacological treatment of type 2 diabetes in elderly patients with heart failure: randomized trials and beyond. Heart failure reviews, Advance online publication. PMID: 34859336.
   PubMed Web of Science ®Google Scholar
• Sepehri, Z., et al., 2016. Toll-like receptor 2 and type 2 diabetes. Cellular & molecular biology letters, 21, 2.
   PubMed Web of Science ®Google Scholar
• Sepp, E., et al., 2014. Higher blood glucose level associated with body mass index and gut microbiota in elderly people. Microbial ecology in health and diseases, 3, 25.
   Google Scholar
• Shang, A., et al., 2019. Bioactive compounds and biological functions of garlic (Allium sativum L.) . Foods, 8 (7), 246.
   PubMed Web of Science ®Google Scholar
• Solis-Herrera, C., et al., 2000. Pathogenesis of type 2 diabetes mellitus. (K. R. Feingold, B. Anawalt, A. Boyce., et al. eds.). South Dartmouth, MA: MDText.com, Inc.
   Google Scholar
• Son, S.H., et al., 2017. In vitro characterization of Lactobacillus brevis KU15006, an isolate from kimchi, reveals anti-adhesion activity against foodborne pathogens and antidiabetic properties. Microbial pathogenesis, 112, 135–141.
   PubMed Web of Science ®Google Scholar
• Tai, N., Wong, F.S., and Wen, L., 2015. The role of gut microbiota in the development of type 1, type 2 diabetes mellitus and obesity. Reviews in endocrine & metabolic disorders, 16 (1), 55–65.
   PubMed Web of Science ®Google Scholar
• Tao, Y.W., et al., 2020. Effects of probiotics on type II diabetes mellitus: a meta-analysis. Journal of translational medicine, 18 (1), 30.
   PubMed Web of Science ®Google Scholar
• Tazakori, Z., Zare, M., and Jafarabadi, M.A., 2017. Probiotic yogurt effect on macronutrients ingredients, blood glucose and lipid profile in type 2 diabetes. JPMA. The journal of the pakistan medical association, 67 (7), 1123.
   PubMed Web of Science ®Google Scholar
• Tonucci, L.B., et al., 2017. Clinical application of probiotics in type 2 diabetes mellitus: A randomized, double-blind, placebo-controlled study. Clinical nutrition, 36 (1), 85–92.
   PubMed Web of Science ®Google Scholar
• van Zyl, W.F., Deane, S.M., and Dicks, L.M.T., 2020. Molecular insights into probiotic mechanisms of action employed against intestinal pathogenic bacteria. Gut microbes, 12 (1), 1831339.
   PubMed Web of Science ®Google Scholar
• Veyhe, A.S., et al., 2019. Prevalence of prediabetes and type 2 diabetes in two non-random populations aged 44-77years in the Faroe Islands. Journal of clinical & translational endocrinology, 16, 100187.
   PubMedGoogle Scholar
• Wang, L., et al., 2014. Effect of oral consumption of probiotic Lactobacillus planatarum P-8 on fecal microbiota, SIgA, SCFAs, and TBAs of adults of different ages. Nutrition, 30 (7-8), 776–783.e1. e771.
   PubMed Web of Science ®Google Scholar
• Wang, Y., et al., 2020. Composite probiotics alleviate type 2 diabetes by regulating intestinal microbiota and inducing GLP-1 secretion in db/db mice. Biomedicine & pharmacotherapy = Biomedecine & Pharmacotherapie, 125, 109914.
   PubMed Web of Science ®Google Scholar
• Wang, Y., et al., 2019. Plasma fetuin-a levels and risk of type 2 diabetes mellitus in a chinese population: a nested case-control study. Diabetes & metabolism journal, 43 (4), 474–486.
   PubMed Web of Science ®Google Scholar
• Wei, M., et al., 2020. Enterococcus hirae WEHI01 isolated from a healthy Chinese infant ameliorates the symptoms of type 2 diabetes by elevating the abundance of Lactobacillales in rats. Journal of dairy science, 103 (4), 2969–2981.
   PubMed Web of Science ®Google Scholar
• WHO. (2001). Probiotics definition by the World Health Organization. https://www.probiotics-lovethatbug.com/probiotics-definition.html
   Google Scholar
• WHO. (2020). Diabetes. https://www.who.int/news-room/fact-sheets/detail/diabetes
   Google Scholar
• Wullt, M., et al., 2007. Lactobacillus plantarum 299v enhances the concentrations of fecal short-chain fatty acids in patients with recurrent clostridium difficile-associated diarrhea. Digestive Diseases and Sciences, 52 (9), 2082–2086.
   PubMed Web of Science ®Google Scholar
• Xu, J., et al., 2015. Structural modulation of gut microbiota during alleviation of type 2 diabetes with a Chinese herbal formula. The ISME journal, 9 (3), 552–562.
   PubMed Web of Science ®Google Scholar
• Yadav, H., et al., 2013. Beneficial metabolic effects of a probiotic via butyrate-induced GLP-1 hormone secretion. The journal of biological chemistry, 288 (35), 25088–25097.
   PubMed Web of Science ®Google Scholar
• Yan, F., et al., 2019. Lactobacillus acidophilus alleviates type 2 diabetes by regulating hepatic glucose, lipid metabolism and gut microbiota in mice. Food & function, 10 (9), 5804–5815.
   PubMed Web of Science ®Google Scholar
• Yan, F., et al., 2019. Screening for Potential Novel Probiotics With Dipeptidyl Peptidase IV-Inhibiting Activity for Type 2 Diabetes Attenuation in vitro and in vivo. Frontiers in microbiology, 10, 2855.
   PubMed Web of Science ®Google Scholar
• Yang, L., et al., 2021. The varying effects of antibiotics on gut microbiota. AMB express, 11 (1), 116–116.
   PubMed Web of Science ®Google Scholar
• Zeng, Z., et al., 2019. Ameliorative effects of probiotic lactobacillus paracasei nl41 on insulin sensitivity, oxidative stress, and beta-cell function in a type 2 diabetes mellitus rat model. Molecular nutrition & food research, 63 (22), e1900457.
   PubMed Web of Science ®Google Scholar
• Zhao, D., et al., 2020. Antidiabetic effects of selenium-enriched Bifidobacterium longum DD98 in type 2 diabetes model of mice. Food & Function, 11 (7), 6528–6541.
   PubMed Web of Science ®Google Scholar